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Abstract
Paracetamol has recently been suggested to affect emotion processing in addition
to alleviating pain in humans. We investigated in adult male Hannover–Wistar rats
whether acute intraperitoneally administrated paracetamol affects behavior in tests
measuring anxiety, mood, motor activity, and memory. Unoperated rats received sal-
ine or a low (50 mg/kg) or high (300 mg/kg) dose of paracetamol, while rats with a
spared nerve injury (SNI) model of neuropathy and sham-operated rats received sal-
ine or the low dose of paracetamol. Rats were tested on open-field (OFT), elevated
plus-maze (EPM), light-dark box (LDB), novel-object recognition (NOR), sucrose pref-
erence, rotarod, and monofilament tests. In unoperated rats, both the low and high
dose of paracetamol reduced line crossings, and grooming time in the OFT, and
novel preference in NOR. The high dose of paracetamol increased the time spent in
the closed arm in EPM, reduced the number of rearings and leanings in OFT, the
time spent in the light box in LDB, and sucrose preference. Paracetamol had no sig-
nificant effect on the rotarod test measuring motor activity. The low dose of parac-
etamol suppressed mechanical pain hypersensitivity in SNI rats, without influencing
pain behavior in sham-operated rats. Saline- but not paracetamol-treated SNI rats
spent more time than sham-operated rats in the closed arm in the EPM test.
Together the results suggest that a high dose of paracetamol increases anxiety-like
and anhedonic behavior, and impairs recognition memory in unoperated controls,
while in neuropathy, a low dose of paracetamol reduces nerve injury-associated
anxiety probably by reducing neuropathic pain.
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1 | INTRODUCTION
Paracetamol, also known as acetaminophen, is a commonly used
medication to alleviate pain and reduce fever. It was accepted to be
safe at the therapeutic dosage and toxic to liver at acute overdose
Abbreviations: EPM, elevated plus-maze; LDB, light-dark box; NOR, novel-object
recognition; OFT, open-field test; SNI, spared nerve injury.
Chemical compounds: paracetamol (Pub Chem CID: 1983).
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administration. Although most studies focus on the hepatotoxicity,
recent studies transferred from hepatotoxicity on neurotoxicity.1
Several recent studies on humans suggest that, in addition to its
well-known pain relieving and fever-reducing effects, paracetamol
may affect a wide variety of cognitive functions. It was shown to
alter how human subjects evaluate negative and positive experi-
ences.2-5 A brain imaging study showed that, compared to a placebo,
daily doses of paracetamol for 3 weeks reduced neural responses to
social rejection in the insula and dorsal anterior cingulate cortex.2
This finding is in line with the suggestion that the pain of social
rejection and physical pain share similar underlying neural mecha-
nisms.3 In addition to social and physical pain, many kinds of unex-
pected events can produce anxiety and unease in humans and, for
that matter, pain. Acute doses of paracetamol have been shown to
ameliorate negative reactions to threats,4 and to reduce discomfort
that people experience when making difficult decisions5 and empa-
thy for pain.6
Paracetamol produces antinociception through mechanisms that
block prostaglandin synthesis by inhibiting the cyclooxygenase
enzymes.7 Also, other mechanisms of action have been suggested
that link paracetamol with the cannabinoid,8,9 opioid, and serotoner-
gic neurotransmitter systems.10 In this study, we investigated
whether acute intraperitoneal administration of paracetamol affects
the behavior of healthy adult rats in tests measuring anxiety, anhe-
donia, motor performance, and memory. Painkillers, however, are
normally taken when subjects experience pain, and not when there
is no pain. We therefore also tested the effect of paracetamol on
rats with a spared nerve injury model (SNI) of neuropathy in the left
hind limb and on sham-operated rats.11 As neuropathy in SNI rats
causes pain and anxiety,12 we investigated how a low dose of parac-
etamol that has been shown to reduce mechanical hypersensitivity
in neuropathic rats13 affects their pain behavior and performance in
the tests that measure anxiety and anhedonia. Based on earlier
reports on healthy human subjects, we hypothesized that acute
effects of systemic paracetamol might reduce anxiety and distress in
healthy rats. We also expected that paracetamol reduces anxiety-
and distress-related behavior as well as pain behavior in neuropathic
rats.
2 | MATERIALS AND METHODS
2.1 | Animals
Adult male Hannover–Wistar rats (weight 200–300 g; age approxi-
mately 7–10 weeks; Harlan, Horst, Netherlands) were used in this
study. The experimental protocols were approved by the Experimen-
tal Animal Ethics Committee of the Provincial Government of South-
ern Finland (H€ameenlinna, Finland), and the experiments were
performed according to the guidelines of European Communities
Council Directive of 22 September 2010 (2010/63/EU). All efforts
were made to limit distress and to use only the number of animals
necessary to produce reliable scientific data. All rats were first
housed in pairs in individual cages in standard laboratory conditions
(room temperature 22°C, humidity 55%) in a 12-h light/dark cycle
(lights on between 6 AM to 6 PM) with ad libitum access to rat chow
and tap water. The rats that underwent sham or SNI operation were
housed singly after the operation. The transparent cages were kept
in the same room, so the rats could hear, see, and smell the other
rats. After their arrival, the rats were first accustomed to the new
living environments for 1 week in a room next to the laboratory
where the tests were run. Then, they were accustomed on 3 days to
the laboratory environment next door. During each of the 3 days, at
about the same time of the day (between 12:00 and 14:00), the rats
spent approximately 2 hours in the laboratory environment and were
handled by the experimenter several times during this period.
2.2 | Surgical procedures for producing neuropathy
The spared nerve injury (SNI) model, as described by Decosterd and
Woolf,11 was adopted for inducing neuropathy. The rat was anaes-
thetized with intraperitoneal (ip) administration of sodium pentobar-
bital (60 mg/kg, Orion Pharma, Espoo, Finland). Additional doses
(15–20 mg/kg ip) were administered if necessary to keep the depth
of anesthesia, so that the animal did not react to noxious stimula-
tion. During surgery, an incision was made into the skin on the lat-
eral surface of the left thigh, followed by a section through the
biceps femoris muscle to expose the sciatic nerve and its terminal
branches: the sural, common peroneal, and tibial nerves. The com-
mon peroneal and tibial nerves were then tightly ligated with 4–0
silk, sectioned distal to the ligation, and 3–4 mm of the distal nerve
stump was removed. The sural nerve was left intact and care was
exercised not to stretch it. In sham-operated rats, the surgical proce-
dure was identical, except that the tibial and common peroneal
nerves were not ligated or sectioned. To prevent postoperative pain,
animals were treated with 0.01 mg/kg of buprenorphine (Orion
Pharma, Espoo, Finland) twice daily for 3 days and they were
allowed to recover for at least a week before the experiments.
2.3 | Assessment of the limb-withdrawal threshold
The assessment of the limb-withdrawal threshold was conducted in
a plexiglas chamber (21 9 15 9 15 cm), which was inverted upon
an elevated metal grid. Before the assessment, the rat was habitu-
ated in the chamber for 2 hours daily for 2 days. The neuropathic
hypersensitivity was verified on the 3rd day by measuring the hind
limb-withdrawal threshold with monofilaments to stimulate the lat-
eral foot pad of hind paws, which is the terminal area of the spared
sural nerve, using methods described in detail elsewhere.14 Briefly, a
series of monofilaments were applied with increasing force ranging
from 0.4 to 60 g (North Coast Medical, Inc., Morgan Hill, CA). For
each force level, the stimulus was repeated five times in a row and
one withdrawal response to the stimulus was considered as 20% of
hypersensitivity. To reduce the bias from experimenter, we mea-
sured the withdrawal response using a blinded test. The percentage
of withdrawal responses at each stimulus intensity represented an
index of hypersensitivity. When assessing the drug-induced effect
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on the limb-withdrawal response rate, the difference in the post-
drug–predrug response was calculated at each test stimulus force
and experimental condition. A drug-induced change in the response
rate that is below < 0 % represents a drug-induced attenuation of
the response. Limb-withdrawal responses were assessed in the
nerve-injured/sham-operated hind limb.
2.4 | Behavioral tests
2.4.1 | Open-field test
The open-field test (OFT) permits assessment of anxiety-like explora-
tory and locomotor behaviors.15 The arena was circular with an 85-
cm diameter white floor and a 50-cm high white wall.16-18 The floor
had three concentric black circles, and the two outer circles were
divided into segments by six radial lines. Each segment in the outer-
most circle was subdivided to two equally large segments by an
additional short radial line, resulting in a total of 19 floor sections of
equal size. The testing was conducted in a bright environment at the
light level of 300 lux. Each animal was placed on a starting point in
the center and then recorded for 5 minutes by a digital video cam-
era. The number of line crossings, the number of rearings and lean-
ings, the time spent grooming, and the number of defecations were
counted by the experimenter from the video recording for the statis-
tical analysis. The time spent in the central area (segments in the
center and middle circle) and the time in the outer area (segments in
the outermost circle) was measured to calculate the percentage (%)
of time spent in the central area for statistics.
2.4.2 | Elevated plus-maze
The elevated plus-maze (EPM) was used to test anxiolytic/anxiogenic
effects of the drugs.19 It consisted of two open arms 45 9 10 cm
and two closed arms 45 9 10 9 35 cm with an open roof, elevated
to 50 cm from the floor and arranged so that the open arms were
opposite to each other.17 The testing was conducted in a bright
environment at the light level of 300 lux. For testing, each animal
was placed in the center of the maze and recorded for 5 minutes by
a digital video camera. The time spent in the center and in the open
and closed arms of the maze was measured. The assessment was
determined by calculating the percentage of time spent in the closed
arm.
2.4.3 | Light-dark box
The plexiglas light-dark box (LDB; 30 9 30 9 30 cm) was con-
structed of two chambers separated by a plexiglas board
(30 9 30 9 15 cm), one of which was covered with black masking
tape, the other was covered with white paper and illuminated by a
cold light source of xenon lamp (100 lux). The device records auto-
matically time spent in each chamber using a computer-controlled
4 9 16 array of photo beams. The box was placed in a dark room,
the illumination being provided exclusively by the xenon lamp. Half
of the rats were individually placed in the center of the white com-
partment facing the opening, whereas the other half of the rats were
individually placed in the center of the dark compartment. The test
lasted for 5 minutes, and the time spent in each compartment was
measured. The LDB assessment was determined by calculating the
percentage of the time spent in light box. A reduction in time spent
in the light box was considered to represent increased anxiety-like
behavior.
2.4.4 | Novel-object recognition
The novel-object recognition (NOR) task was based on the protocols
described previously20-22 with some modifications. Testing was car-
ried out in a circular arena with a white 85 cm diameter floor and
50 cm high wall. The arena was illuminated by four 40 W fluores-
cent lamps which provided a constant light level of 300 lux. A digital
video camera was positioned above the arena and was used to
record behavior during testing for subsequent analysis. The objects
were plastic Coca-Cola bottles (filled with water) with a base diam-
eter of 6.5 and 23.5 cm height and two stacked plastic Rubik’s cubes
with the side length of 5.7 cm and height of 11.4 cm. The objects
had no apparent natural significance to the rats, and were secured
to the base of the arena with adhesive plaster. Animals were habitu-
ated to the arena in the absence of objects for 20 minutes on the
day before the test day. The test day comprised of three stages:
habituation, exposure 1 and exposure 2. Rats were first introduced
to the arena for a 3-minutes habituation period and then returned to
their home cage for 7 minutes. During exposure 1, two identical
objects (Coca-Cola bottles) were placed in opposite quadrants of
the arena, 16 cm from the perimeter. The rat was allowed to freely
explore the arena and the objects for a period of 3 minutes, after
which the animal was removed from the arena and returned to its
home cage for an interval of 5 minutes. Prior to exposure 2, one of
the bottles was replaced with the novel object (two stacked plastic
Rubik’s cubes). The animal was again allowed to freely explore the
objects for a period of 3 minutes in the arena and then returned to
its home cage. The arena was cleaned with 70 % ethanol between
rats to remove odors and olfactory cues, and fecal pellets were
removed between exposures. Exploration of an object was defined
as sniffing the object, rearing against the object, or having the head
directed toward the object within a 2 cm annulus of the object. The
NOR assessment was determined by calculating a discrimination
ratio as follows: (Total time spent for exploring either object)/(Total
time spent for exploring both objects).
2.4.5 | Sucrose preference test
The rat was kept in the home cage and, during a time period of
20:00–8:00, was presented with two bottles: one filled with tap
water and the other with 0.8 % sucrose solution (200 mL each). The
12-hour consumption of water and sucrose solution was calculated
by weighing the bottles both before and after the test, and by sub-
tracting the weight of the bottle after test from the weight before
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the test. Sucrose preference percentage (%) was the ratio of the
sucrose solution consumption divided by the total fluid consumption
(i.e., water plus sucrose), multiplied by 100. A reduction in sucrose
preference was considered to represent anhedonia.23
2.4.6 | Rotarod test
The locomotor activity of the rats was assessed in the rotarod test,
in which animals walk on a rotating drum (Ugo Basile, Varese, Italy).
After starting the rotarod test device, the speed was increased to
the maximum revolution speed (26 revolutions/min) in 2 revolu-
tions/s. The rat was trained 5 minutes per day for 2 days to stay on
the drum. On the third day, performance was assessed once by mea-
suring the duration (seconds) that the rat stayed up on the drum at
the maximum drum speed.
2.5 | Course of the study
Totally 10 separate groups (n = 6) of rats were used in this study.
Groups 1, 2, and 3 received an ip injection of saline (10 mL/kg), a
low dose of paracetamol (50 mg/kg, 10 mg/mL, Orion Pharma,
Espoo, Finland), or a high dose of paracetamol (300 mg/kg, 10 mg/
mL), respectively. The behavioral tests, in the order of OFT, EPM
and LDB, with a 10-minute interval between the tests, were started
90 minutes after the injection. All behavioral tests, except the
sucrose preference test, were conducted during the light cycle
phase. The drug injections were given in the early afternoon
between 12:00 and 13:00. For the sucrose preference test, the drug
injection was given at 19:45 in the evening. The paracetamol doses
and the time point of testing after drug injection were based on an
earlier study reporting dose-dependent antinociceptive effects of
intraperitoneally injected paracetamol.13 After an interval of 3 days,
the rats received an ip injection of saline (10 mL/kg), paracetamol
(50 mg/kg) or paracetamol (300 mg/kg), respectively, at 19:45 on
the fourth day and were put back to their home cages for the
sucrose preference test.
Groups 4, 5, and 6 were trained for the rotarod test on 2 days
(the first and second day) and were habituated for NOR on the sec-
ond day. On the third day, the rats received an ip injection of saline
(10 mL/kg), paracetamol (50 mg/kg), or paracetamol (300 mg/kg),
respectively. The NOR started at 90 minutes after the injection.
After an interval of 10 minutes in the home cage, the rat performed
the rotarod test.
Groups 7 and 9 received sham surgery and Groups 8 and 10 the
SNI surgery. After a recovery period of 1–2 weeks, all rats were
trained for the assessment of the limb-withdrawal threshold on
2 days. On the third day, the limb-withdrawal threshold was
assessed five times at each force level. After the assessment, Groups
7 and 8 received an ip injection of saline (10 mL/kg), and Groups 9
and 10 received an ip injection of a low dose of paracetamol
(50 mg/kg) and, at 80 minutes after the injection, the limb-withdra-
wal threshold was again assessed to test the analgesic effect of
paracetamol.
The behavioral tests, in the order of OFT, EPM, and LDB, with a
10-minute interval between the tests, started 90 minutes after the
injection. After an interval of 3 days, the rats received an ip injection
of saline (10 mL/kg) or paracetamol (50 mg/kg) at 19:45 on the
fourth day and were put back to the home cage for the sucrose
preference test.
2.6 | Statistical analysis
Statistical evaluation of the data was performed using a one-, two-
or three-way ANOVA followed by Bonferroni-corrected t tests, or a
t test when comparing only two groups. In all tests, P < .05 was con-
sidered to represent a statistically significant difference.
3 | RESULTS
Tables 1 and 2 summarize the results of the behavioral tests in
unoperated and operated rats.
3.1 | Behavioral tests in unoperated rats
3.1.1 | Open-field test (OFT)
The number of line crossings differed significantly between the drug
treatment groups (F(2,15) = 11.414, P = .001, one-way ANOVA,
Figure 1A). Both the low- and high-dose paracetamol groups (50
and 300 mg/kg, respectively) made fewer line crossings than the
saline group (low-dose group vs saline, P = .010; high-dose group
vs saline, P = .001, Bonferroni test), but the paracetamol-treated
groups did not differ from each other. Treatment also affected the
number of rearings and leanings (Figure 1B; F(2,15) = 8.003,
P = .004, one-way ANOVA); the high-dose group had lower scores
than the saline group (P = .004), whereas the low-dose group did
not differ significantly from the saline (P = .078) or high-dose
(P = .463) groups. Also, the grooming time differed significantly
between the groups (Figure 1C; F(2,15) = 8.443, P = .003, one-way
ANOVA); both the low- (P = .008) and the high-dose (P = .009)
groups had shorter grooming times than the saline group. There
was no statistically significant difference between the groups in the
number of defecations (F(2,15) = 0.345, P = .714) and the percentage
of the time spent in the central area (F(2,15) = 0.160, P = .853, one-
way ANOVA).
3.1.2 | Elevated plus-maze (EPM)
Treatment affected the performance in the EPM test, so that the
time spent in the closed arm differed between the groups
(F(2,15) = 7.151, P = .007, one-way ANOVA, Figure 1D). The high-
dose group (300 mg/kg) spent more time in the closed arm than
the low-dose (50 mg/kg; P = .025) and saline groups (P = .010), but
the low-dose group did not differ significantly from the saline
group.
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3.1.3 | Light-dark box (LDB)
Treatment had a significant effect on the time the groups spent in
the light box (F(2,15) = 4.333, P = .033 one-way ANOVA, Figure 1E).
The high-dose paracetamol group (300 mg/kg) spent a significantly
shorter time in the light box than the saline group, (P = .032) but
the low-dose group (50 mg/kg) did not differ significantly from the
high-dose or saline groups.
3.1.4 | Sucrose preference test
Treatment had a main effect on the sucrose preference
(F(2,15) = 20.813, P < .001, one-way ANOVA, Figure 1F). Post hoc
tests showed that the high dose of paracetamol (300 mg/kg) signifi-
cantly decreased sucrose preference compared to both the low dose
of paracetamol (50 mg/kg) and saline groups (P < .001 in both tests),
but the low-dose group did not differ significantly from the saline
group. After balancing the volume of saline and paracetamol
injected, the rats in the high-dose group still preferred water over
sucrose (t12 = 4.472, P = .001, t test) indicating that the volume
injected did not affect the preference.
3.1.5 | Rotarod test
Figure 1G shows the performance of the rats in the rotarod test.
The three groups of rats performed the rotarod test in a comparable
TABLE 1 Behavioral tests in unoperated rats
Tests Saline Low dose Effect High dose Effect
OFT
Line crossing (#) 52.33  4.00 28.33  7.18 ↓ 20.67  2.04 ↓↓
Rearing and Leaning (#) 19.33  1.52 10.83  3.57 ↔ 5.67  1.65 ↓↓
Grooming time (s) 15.83  3.66 2.33  1.31 ↓↓ 2.50  2.50 ↓↓
Defecation (#) 1.00  1.00 1.83  1.08 ↔ 2.00  0.58 ↔
Center time (%) 7.50  1.62 5.72  2.52 ↔ 5.83  3.10 ↔
EPM
Closed Arm Time (%) 61.3  6.76 64.88  5.42 ↔ 89.06  4.54 ↑
LDB
Light box time (%) 54.61  3.48 43.44  2.89 ↔ 38.94  4.96 ↓
Sucrose preference
Sucrose preference (%) 90.79  2.78 92.29  1.66 ↔ 38.06  11.46 ↓↓↓
Rotarod
Drop latency (s) 112.17  31.73 143.83  24.03 ↔ 65.33  12.22 ↔
OFT, Open-Field Test; EPM, Elevated Plus Maze; LDB, Light-Dark Box; Effect, effect vs saline; ↑, significant increase; ↓, significant decrease; ↔, no sig-
nificant change. # = number. One arrow = P < .05; two arrows = P < .01; three arrows = P < .001.
TABLE 2 Behavioral tests in operated Sham and SNI rats
Tests
Sham SNI
Saline Paracet. Eff. Saline Paracet. Eff.
OFT
Line crossing (#) 52.17  13.46 41.33  5.48 ↔ 18.83  5.24 27.83  7.76 ↔
Rear/Lean (#) 19.50  5.43 8.00  1.84 ↓ 4.17  1.22 1.33  0.42 ↔
Grooming (s) 6.33  3.00 4.50  2.92 ↔ 4.33  2.93 2.67  2.67 ↔
Defecation (#) 2.83  0.98 1.67  0.42 ↔ 2.00  2.61 1.00  1.06 ↔
Center time (%) 11.33  3.30 6.06  2.04 ↔ 6.22  3.17 3.22  1.14 ↔
EPM
Closed Arm Time (%) 59.94  4.85 57.94  5.51 ↔ 85.56  3.49 60.11  6.41 ↓
LDB
Light box time (%) 52.22  4.40 53.67  3.19 ↔ 33.72  3.15 35.5  1.89 ↔
Sucrose Pref.
Sucrose pref. (%) 91.34  2.38 94.17  1.06 ↔ 96.73  0.60 93.78  1.08 ↔
SNI, spared nerve injury; OFT, Open-Field Test; EPM, Eleveated Plus Maze; LDB, Light-Dark Box; Rear/Lean, Rearings and Leanings; Pref., preference;
Paracet., Paracetamol 50 mg/kg; # = number; Eff., effect vs saline; ↑, significant increase; ↓, significant decrease; ↔, no significant change. One
arrow = P < .05.
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manner during the predrug period, as the performances of the
groups did not differ statistically significantly from each other
(F(2,15) = 0.781, P = 0.476, one-way ANOVA). Moreover, treatment
had no significant effect on their performance (postdrug;
F(2,15) = 2.699, P = .100, one-way ANOVA).
3.1.6 | Novel-object recognition (NOR)
There were no statistically significant main effects of exposure, drug
or object on the NOR test, but the three-way interaction of expo-
sure, drug, and object was significant (F(2,15) = 4.665, P = .017,
mixed design ANOVA; within-subjects variable: exposure; between-
subjects variable: drug and object, Figure 2). Tests of simple effects
of this interaction showed that the saline-treated group recognized
the novel from familiar objects in the second exposure (F(1,5) = 8.81,
P = .006).
3.2 | Behavioral tests in operated rats
3.2.1 | Verification of neuropathic hypersensitivity
The SNI rats showed significant hypersensitivity to the monofilament
stimulus in the limb-withdrawal test compared to sham-operated rats
(main effect of operation: F(1,10) = 6.85, P = .026, two-way mixed
design ANOVA, Figure 3A).
3.2.2 | Effect of paracetamol on mechanical
hypersensitivity
In SNI rats, paracetamol at a low dose (50 mg/kg) significantly
decreased mechanical hypersensitivity (Figure 3B) in the injured hind
limb (main effect treatment: F(1,10) = 14.94, P = .003, two-way mixed
























































































































F IGURE 1 Results of behavioral tests in unoperated rats. (A) The number of line crosses in the open-field test (OFT) in saline, low-dose
and high-dose groups. (B) The number of rearings and leanings in OFT. (C) The grooming time in OFT. (D) The percentage of time in the
closed arm in the elevated plus-maze test. (E) The percentage of time spent in the light box in the light-dark box test. (F) Consumption of
sucrose-containing water as a percentage of total water consumption in the sucrose preference test. (G) Locomotion in the rotarod test,
measured as the time (s) on the drum (=drop latency). Low dose: 50 mg/kg of paracetamol, High dose: 300 mg/kg of paracetamol. Error bars
indicate SEM (n = 6). *P < .05, **P < .01, ***P < .001 (Bonferroni-corrected t test)
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the response rate (main effect of treatment: F(1,10) = 3.245,
P = 0.102, Figure 3C).
Further behavioral tests assessing effect of paracetamol on anxi-
ety and anhedonia in SNI rats were performed only at a low dose of
paracetamol (50 mg/kg), compared with saline that proved high
enough to suppress the SNI-induced hypersensitivity.
3.2.3 | Open-field test (OFT)
Operation, but not the drug treatment, had a significant main effect
on the number of line crossings (main effect of operation:
F(1,20) = 7.333, P = .014, two-way ANOVA, Figure 4A) in the OFT.
SNI rats made fewer line crossings than sham-operated rats indepen-
dent on drug treatment. Operation had a significant main effect also
on the number of rearings and leanings (F(1,20) = 13.993, P = .001,
two-way ANOVA, Figure 4B) that was smaller in SNI than sham-
operated rats. Also, drug treatment had a significant main effect on
the number of rearings and leanings (F(1,20) = 5.910, P = .024, two-
way ANOVA) that was smaller in rats treated with the low dose of
paracetamol compared to saline.
Operation had no significant main effect on the grooming time
(F(1,20) = 0.443, P = .513), the number of defecations (F(1,20) = 0.935,
P = .345), or duration in the central area (F(1,20) = 2.393, P = .138).
Also, drug treatment had no significant main effect on the grooming
time (F(1,20) = 0.369, P = .550), number of defecations
(F(1,20) = 1.952, P = .178), or time in the central area (F(1,20) = 2.598,
P = .123).
3.2.4 | Elevated plus-maze (EPM)
There was a significant main effect of operation (F(1,20) = 7.726,
P = .012, two-way ANOVA) and drug treatment (F(1,20) = 7.548,
P = .012), and a significant operation 9 drug treatment interaction
(F(1,20) = 5.575, P = .028) on the time the rats spent in the closed
arm in the EPM test. Saline-treated SNI rats spent a significantly
longer time in the closed arm compared to saline-treated sham-oper-
ated rats (P = .022) and to SNI rats treated with paracetamol
(50 mg/kg; P = .01; Figure 4C).
3.2.5 | Light-dark box (LDB)
Operation had a main effect on activity in the light-dark box test
(F(1,20) = 31.272, P < .001, two-way ANOVA). The percentage of
time spent in the light box was significantly smaller in SNI rats than



























F IGURE 2 Novel-object recognition in unoperated rats. Exposure 1 shows the difference of discrimination ratio between Object 1 and
Object 2. Exposure 2 shows the difference of discrimination ratio between the Familiar object and the Novel object. Low dose: 50 mg/kg of
paracetamol, High dose: 300 mg/kg of paracetamol. Error bars indicate SEM (n = 6). **P < .01 (Bonferroni-corrected t test)
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F IGURE 3 Verification of the spared nerve injury (SNI) model and the effect of paracetamol on mechanical hypersensitivity. The limb-
withdrawal response rate (A) in the hind limb ipsilateral to the operation in sham and SNI rats before drug treatment, and the drug treatment-
induced change in the limb-withdrawal response rate in SNI (B) and sham-operated animals (C). Paracetamol was given at the dose of 50 mg/
kg. In a, the Y-axis shows the response rate at different test stimulus forces; the higher the response rate, the stronger the hypersensitivity. In
B and C, the Y-axis shows the difference in the postdrug–predrug response at each test stimulus force; 0% represents the corresponding
predrug value and differences <0% represent drug-induced reductions in the response. All tests were performed in the nerve-injured or sham-
operated hind limb. Error bars indicate SEM (n = 6). *P < .05, **P < .01, ***P < .005 (reference: the corresponding value in the saline-treated
group; Bonferroni-corrected t test)
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in sham-operated rats (P = .002, Figure 4D). Drug treatment, on the
other hand, had no significant main effect on activity in the light-
dark box test (F(1,20) = .242, P = .628, two-way ANOVA, Figure 4D).
3.2.6 | Sucrose preference test
Neither the operation (between-subject effect: F(1,10) = 1.499,
P = .249, mixed design two-way ANOVA) nor the drug treatment
(within-subject effect: F(1,10) = 0.349, P = .568) affected the sucrose
preference (Figure 4E).
4 | DISCUSSION
4.1 | Effect of paracetamol on healthy control rats
In general, paracetamol influenced emotional and cognitive behavior
of the unoperated rats in a way that varied with the paracetamol
dose and the behavioral test. Two parameters presumably gauging
some aspects of emotionality in the OFT, the center time and defe-
cation,24 were not influenced by paracetamol (50 or 300 mg/kg).
The number of line crossings, rearings and leanings as well as the
time used for grooming in the OFT were suppressed in a dose-
related fashion by paracetamol treatment. Motor impairment is not
likely to explain these decreases in the OFT behavior, as locomotor
performance in the rotarod test was not suppressed by paracetamol.
In the EPM test, paracetamol increased the time spent in the closed
arm and in the LDB test paracetamol decreased the time spent in
light. Both of these changes are considered to represent an increase
in anxiety-like behavior.25 Sucrose preference was significantly
reduced by the high but not low dose of paracetamol suggesting
that paracetamol has a dose-related anhedonic effect. All these
results are consistent with the interpretation that a high (300 mg/kg)
but not a low (50 mg/kg) dose of paracetamol produces in healthy
control rats a mood change that has a negative valence as reflected
by increased anxiogenic-like and anhedonic behavior. Moreover,
paracetamol impaired cognitive performance as suggested by the
finding that the performance in the NOR test that assesses recogni-
tion memory was suppressed in paracetamol-treated healthy control
animals. However, it has been suggested that the NOR test involves
two cognitive processes, “familiarity recognition” and “novelty pref-
erence,”26 of which only “familiarity recognition” involves memory.
Therefore, further studies using additional memory tests are still
needed to confirm whether the paracetamol-induced change in cog-
nitive performance in the NOR test was due to an action on mecha-
nisms underlying familiarity recognition or novelty preference.
Anyway, the present result showing impaired cognitive performance
of unoperated rats in the NOR test following a high dose of parac-
etamol is in line with clinical observations in elderly humans whose
cognitive capacity is reduced by high acute doses of paracetamol.27
Earlier, paracetamol was shown to have a dose-related (up to
200 mg/kg) anxiolytic-like effect on the mouse Vogel conflict, social
interaction,28 and EPM tests.29 The paracetamol-induced anxiolytic-
like effect on mice was mediated by the endocannabinoid system, as

























































































F IGURE 4 Results of behavioral tests in nerve-injured (SNI) and sham-operated rats. (A) The number of line crosses in the open-field test
(OFT). (B) The number of rearings and leanings in OFT. (C) The percentage of the time spent in the closed arm in the elevated plus-maze test.
(D) The percentage of time spent in the light box in the light-dark box test. (E) Consumption of sucrose-containing water as a percentage of
total water consumption in the sucrose preference test. Paracetamol: 50 mg/kg. Error bars indicate SEM (n = 6). *P < .05, **P < .01
(Bonferroni-corrected t test)
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should be noted that the behavioral assessments in the mouse stud-
ies showing anxiolytic-like effects by low to moderate doses of
paracetamol were performed 30 minutes after drug administra-
tion.28,29 In the present rat study showing anxiogenic-like effects by
a high dose of paracetamol, the time point of testing was 90–
120 minutes after drug administration that represents the time point
for the peak effect of paracetamol.13,30
4.2 | Effect of paracetamol on animals with
experimental neuropathy
In SNI rats, paracetamol had a significant antihypersensitivity effect
at a low dose (50 mg/kg) that was subantinociceptive in sham-oper-
ated animals. This finding is in line with an earlier study showing that
50 mg/kg of paracetamol reduced mechanical allodynia in neuro-
pathic rats,13 and with a recent study that used a diabetic mouse
model and showed that paracetamol (5-100 mg/kg) alleviated dia-
betic nociceptive pain in a dose-dependent manner.31 It is known
that paracetamol is potentially hepatotoxic especially when used in
high doses.1 The finding of this study that a low dose of paracetamol
that does not elevate hepatic enzymes in rats13 alleviated neuro-
pathic pain without increasing anxiety-like or anhedonic behavior
may be relevant also for human medicine. In the future, the effects
of higher paracetamol doses on pain and anxiety-like behavior in
neuropathic rats should be tested to investigate whether the anxio-
genic-like and anhedonic behavior that was observed in healthy con-
trol rats after a high dose of paracetamol might also appear in
neuropathic rats.
Paracetamol is thought to have a central analgesic and antihyper-
algesic effect through multiple mechanisms.7-9,32,33 The analgesic
effect has been suggested to be mediated by inhibiting the prosta-
glandin synthesis7 and through modulation of the serotonergic and
other monoaminergic neurotransmissions.34 Additionally, a peripheral
antiallodynic and antihyperalgesic effect of paracetamol that involves
adenosine A135 and cannabinoid36 receptors has been demonstrated.
The present results do not allow concluding whether the attenuation
of neuropathic hypersensitivity in SNI rats was due to central,
peripheral, or both of these mechanisms. In SNI animals, the OFT
test showed reductions in line crossings, and rearings and leanings,
which may be explained by SNI rather than paracetamol treatment,
as the reductions were not different between saline- and paraceta-
mol-treated SNI animals.
SNI per se increased anxiety as revealed by the comparison of
saline-treated SNI and sham animals in the EPM and LDB tests. This
is in line with earlier results showing that SNI produces anxiety-like
behavior in the EPM test that is not explained by motor impair-
ment.12 The development of anxiety-like behavior in the SNI model
may, however, vary with the time point of testing after nerve injury,
as an earlier study reported that it may take up to 5–9 weeks to
observe an anxiety-like behavior in the EPM test,37 while in this
study it was observed during the third postoperative week. The
model of experimental neuropathy also influences the development
of anxiety-like behavior as indicated by the earlier finding that both
the partial sciatic nerve ligation model and the chronic constriction
injury model induced pain hypersensitivity but only the latter model
induced anxiety-like behavior.38
In SNI animals, administration of paracetamol at a low (50 mg/
kg) dose reduced anxiety-like behavior in the EPM but not LDB test.
This discrepancy in the EPM and LDB results may reflect different
sensitivity of these two tests of anxiety-like behavior. Concerning
the paracetamol-induced reduction in anxiety-like behavior in the
EPM test, a plausible explanation is that paracetamol reduced anxi-
ety-like behavior indirectly by attenuating neuropathic pain that per
se was causing anxiety. This explanation is in line with earlier results
showing that impairment of visual attention by visceral pain was
reversed by suppressing pain using a moderate (200 mg/kg) dose of
paracetamol.39 In this study, however, we cannot exclude the possi-
bility that in the brain of SNI animals, paracetamol had a direct anxi-
olytic effect through action on mood mechanisms, although this
explanation is not supported by the finding that in unoperated rats,
paracetamol produced a dose-related anxiogenic-like rather than
anxiolytic-like effect. In the sucrose preference test, neither SNI per
se nor a low (50 mg/kg) dose of paracetamol induced a change in
the behavior of SNI animals. This is in line with some earlier results
reporting that during the third postoperative week, SNI did not influ-
ence performance in the forced-swimming test that, as the sucrose
preference test, is used to assess depression-like behavior.12,24 Time
course for the development of depression-like behavior or anhedonia
in the SNI model may be longer than the current postoperative time
point of testing as suggested by the earlier finding that depression-
like behavior in the forced-swimming test was described in the
eighth postoperative week.40
5 | CONCLUSIONS
In healthy rats, acute administration of paracetamol produced a
dose-related increase of anxiety-like and anhedonic behavior. This
was accompanied by reduced cognitive performance in the novel-
object recognition test. In neuropathic rats, a low dose of paraceta-
mol that was subantinociceptive in sham-operated controls had a
marked antihypersensitivity effect that was associated with anxi-
olytic-like effect. Anxiolytic-like effect of paracetamol on neuropathic
animals may be explained by attenuation of neuropathic pain that
was driving anxiogenesis.
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